Align Technology (ALGN) Competitors

Align Technology (NASDAQ:ALGN) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Which has more volatility & risk, ALGN or ZBH?

Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Which has stronger valuation and earnings, ALGN or ZBH?

Zimmer Biomet has higher revenue and earnings than Align Technology. Zimmer Biomet is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$3.86B	4.33	$445.05M	$5.86	38.20
Zimmer Biomet	$7.39B	2.94	$1.02B	$5.26	20.78

Do analysts recommend ALGN or ZBH?

Align Technology presently has a consensus target price of $276.38, indicating a potential upside of 23.45%. Zimmer Biomet has a consensus target price of $123.22, indicating a potential upside of 12.73%. Given Align Technology's stronger consensus rating and higher probable upside, equities analysts plainly believe Align Technology is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.40
Zimmer Biomet	2 Sell rating(s)	12 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.20

Does the media favor ALGN or ZBH?

In the previous week, Zimmer Biomet had 9 more articles in the media than Align Technology. MarketBeat recorded 18 mentions for Zimmer Biomet and 9 mentions for Align Technology. Align Technology's average media sentiment score of 1.43 beat Zimmer Biomet's score of 1.05 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	13 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer ALGN or ZBH?

Zimmer Biomet received 116 more outperform votes than Align Technology when rated by MarketBeat users. However, 69.72% of users gave Align Technology an outperform vote while only 67.24% of users gave Zimmer Biomet an outperform vote.

Company	Underperform	Outperform
Align Technology	Outperform Votes 783 69.72%	Underperform Votes 340 30.28%
Zimmer Biomet	Outperform Votes 899 67.24%	Underperform Votes 438 32.76%

Do institutionals and insiders hold more shares of ALGN or ZBH?

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are owned by institutional investors. 0.6% of Align Technology shares are owned by insiders. Comparatively, 1.0% of Zimmer Biomet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is ALGN or ZBH more profitable?

Zimmer Biomet has a net margin of 14.27% compared to Align Technology's net margin of 11.15%. Align Technology's return on equity of 13.99% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	11.15%	13.99%	8.53%
Zimmer Biomet	14.27%	12.95%	7.55%

Summary

Align Technology beats Zimmer Biomet on 10 of the 18 factors compared between the two stocks.